Clinical Scenarios: Treating Patients with Gastric Cancer

EP. 1: Dr. Shah on the Importance of Genetic Testing in GI Cancer

July 6th 2022

Manish A Shah, MD, discusses the importance of genetic testing in gastrointestinal cancer.

EP. 2: Dr. Brenner on the Role of Trastuzumab Deruxtecan in Gastric Cancer

July 7th 2022

Warren S. Brenner, MD, discusses the utilization of fam-trastuzumab deruxtecan-nxki (Enhertu) as a HER2-directed therapy in gastric cancer.

EP. 3: Dr. Rajdev on Detecting HER2 Positivity in GI Cancer

July 7th 2022

Lakshmi Rajdev, MD, MS, discusses detecting HER2 positivity in patients with gastrointestinal cancers.

EP. 4: Treating Patients with Gastric Cancer

August 25th 2022

This publication highlights a scientific interchange held to evaluate recent data on therapeutic options for advanced gastric and gastroesophageal cancers, explore evidence-based therapy approaches and sequencing strategies in patients with HER2+ disease, and discuss methods to optimize treatment selection and management.